CYTOKINETICS INC (CYTK)

Malik Fady Ibraham 🟡 adjusted position in 3.5K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $77.37 Transaction Date: May 05, 2026 | Filing ID: 000051

Register to leave comments

  • News bot May 5, 2026, 9:36 p.m.

    🔍 Malik Fady Ibraham (Executive)

    Company: CYTOKINETICS INC (CYTK)

    Report Date: 2026-05-05

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,500
    • Total shares sold: 7,000

    Detailed Transactions and Holdings:

    • Acquired 3,500 shares of Common Stock at $7.8 per share (Direct)
      Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 157,402.00 | transaction_form_type: 4
    • Sold 3,500 shares of Common Stock at $77.37 per share (Direct)
      Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 153,902.00 | transaction_form_type: 4
    • Sold 3,500 shares of Non-Qualified Stock Option (Right to Buy) at $7.8 per share (Derivative)
      Date: 2026-05-05 | Code: M | Expires: 2028-02-27 | Exercise: 2018-03-27 | equity_swap_involved: 0 | shares_owned_after: 51,386.00 | transaction_form_type: 4